Stress hyperglycemia is associated with early neurologic deterioration in patients with acute ischemic stroke after intravenous thrombolysis without hemorrhagic transformation
- PMID: 39587672
- PMCID: PMC11590288
- DOI: 10.1186/s13098-024-01537-z
Stress hyperglycemia is associated with early neurologic deterioration in patients with acute ischemic stroke after intravenous thrombolysis without hemorrhagic transformation
Abstract
Background: This aimed to elucidate the impact of stress hyperglycemia on early neurological deterioration (END) in patients with acute non-cardiogenic cerebral infarction who did not experience hemorrhagic transformation following intravenous thrombolysis to identify risk factors associated with END.
Methods: This retrospective case-control study analyzed data from consecutive patients who received intravenous thrombolysis for acute ischemic stroke (AIS) without hemorrhagic transformation at the Stroke Center of The Fifth Affiliated Hospital of Sun Yat-sen University from January 2018 to February 2023. END was defined as an increase of more than 2 points on the National Institutes of Health Stroke Scale (NIHSS) within 7 days of admission.
Results: A total of 250 patients (56 males, 22.4%) were included, with a mean age of 63.34 ± 12.90 years. Of them, 41 were classified into the END group and 209 into the non-END group. Stress hyperglycemia ratio (SHR) demonstrated a significant correlation with END (r=-0.003, P = 0.003). HbA1c (OR = 0.68, 95% CI: 0.481-0.921) and SHR (OR = 0.00, 95% CI: 0.0-0.051) were independently associated with END. Receiver-operating characteristic (ROC) curve analysis indicated that SHR had a sensitivity of 79.9%, specificity of 88.8%, and an area under the curve (AUC) of 0.857 for predicting END.
Conclusions: SHR was significantly associated with END in patients with acute non-cardioembolic cerebral infarction who did not undergo hemorrhagic transformation after intravenous thrombolysis.
Keywords: Acute ischemic stroke; Early neurologic deterioration; Hemorrhagic transformation; SHR.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University(K557). The requirement for individual consent was waived by the committee owing to the retrospective nature of the study. All procedures performed in this study involving human participants were in accordance with the ethical standards of The Fifth Affiliated Hospital of Sun Yat-Sen University committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Competing of interests: All authors declare that they have no competing interests.
Figures
Similar articles
-
Effects of PCSK9 Inhibitors on Early Neurologic Deterioration in Patients with Acute Non-Cardioembolism without Hemorrhagic Transformation After Intravenous Thrombolysis.Curr Neurovasc Res. 2024;21(3):310-319. doi: 10.2174/0115672026332171240624100802. Curr Neurovasc Res. 2024. PMID: 38994623
-
A High Fibrinogen-to-Albumin Ratio on Admission is Associated with Early Neurological Deterioration Following Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.J Inflamm Res. 2024 Jun 27;17:4151-4161. doi: 10.2147/JIR.S459161. eCollection 2024. J Inflamm Res. 2024. PMID: 38952563 Free PMC article.
-
Effects of glycemic indicators on early neurological outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis.World J Diabetes. 2025 Mar 15;16(3):94491. doi: 10.4239/wjd.v16.i3.94491. World J Diabetes. 2025. PMID: 40093278 Free PMC article.
-
Association of the stress hyperglycemia ratio and clinical outcomes in patients with stroke: A systematic review and meta-analysis.Front Neurol. 2022 Sep 1;13:999536. doi: 10.3389/fneur.2022.999536. eCollection 2022. Front Neurol. 2022. PMID: 36119678 Free PMC article.
-
Risk Factors and Outcomes of Hemorrhagic Transformation in Acute Ischemic Stroke Following Thrombolysis: Analysis of a Single-Center Experience and Review of the Literature.Medicina (Kaunas). 2025 Apr 14;61(4):722. doi: 10.3390/medicina61040722. Medicina (Kaunas). 2025. PMID: 40283013 Free PMC article. Review.
Cited by
-
Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions.J Thromb Thrombolysis. 2025 Apr 26. doi: 10.1007/s11239-025-03104-3. Online ahead of print. J Thromb Thrombolysis. 2025. PMID: 40281267 Review.
References
-
- Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L. Global, regional, and national burden of ischemic stroke, 1990–2019. Neurology. 2022;98(3):e279–90. - PubMed
-
- Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in patients with stroke and transient ischemic attack: a Guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–467. - PubMed
-
- Hankey GJ, Stroke. Lancet. 2017;389(10069):641–54. - PubMed
-
- Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86(1):87–94. - PubMed
-
- Lyden P. Using the national institutes of health stroke scale: a cautionary tale. Stroke. 2017;48(2):513–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources